Rouzbeh Banan

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica

Published: February 21, 2026

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica

Published: August 26, 2025

Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomas.

Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomas.

Journal: Acta neuropathologica

Published: August 06, 2025

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes.

Journal: Nature cancer

Published: July 26, 2025

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

Journal: Neuro-oncology

Published: July 22, 2025

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Advancing sarcoma diagnostics with expanded DNA methylation-based classification.

Journal: medRxiv : the preprint server for health sciences

Published: July 09, 2025

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Journal: medRxiv : the preprint server for health sciences

Published: June 10, 2025

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.

Journal: Cancer cell

Published: May 06, 2025

Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes.

Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes.

Journal: Neuro-oncology

Published: April 18, 2025

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.

Journal: Neuro-oncology

Published: March 20, 2025

Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathy.

Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathy.

Journal: Orphanet journal of rare diseases

Published: December 01, 2024

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

Journal: Acta neuropathologica

Published: October 22, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026